Skip to content

Study on the clinical mechanism of Tongjing and Stomach Method abdominal massage in the treatment of chronic insomnia with gastric apnea

Study on the clinical mechanism of Tongjing and Stomach Method abdominal massage in the treatment of chronic insomnia with gastric apnea

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005833
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-06-22
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Massage therapy group:Menstruation and gastric massage group
Positive drug treatment group:Pachyma Compound Digestive Tonic Pill

Sponsors

Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria of chronic insomnia with gastric loss and health; 2. Meet the diagnostic criteria for chronic insomnia and stomach loss and health, sleep and wake difficulties cannot be better explained by other types of sleep disorders, and meet the following 7 conditions: ? Meet the diagnostic criteria of insomnia disorder, meet the primary insomnia criteria of heart and spleen deficiency; ? Persons aged 50 =55; ? Did not participate in other clinical investigators; ? Sign informed consent to participate in this study voluntarily; (5) Pittsburgh sleep Index (PSQI) score >7, AIS score >6. SDS and SAS scores =60; ? During the observation period, there was no work pressure or life pressure; (7) Cardiovascular diseases and other organic diseases; Routine hematuria, electrocardiogram, electroencephalogram, liver and kidney function, blood glucose and lipid and other physical and chemical examination indicators were normal. 3. Patients with above symptoms lasting for more than 1 year and frequency =3 times/week can be included in this study.

Exclusion criteria

Exclusion criteria: If a subject meets any of the following conditions, he/she will not be allowed to participate in the study. 1. Insomnia patients caused by excessive anxiety and depression; 2. Respiratory related sleep disorders, circadian rhythm sleep disorders and sleep disorders; 3. Insomnia patients suffering from systemic diseases such as pain, fever, cough, etc.; 4. Patients with cardiovascular, lung, liver, kidney, hematopoietic system and other serious primary diseases; 5. Patients with mental illness; 6. The skin at the treatment site is infected or hypersensitive; 7. Patients with progressive malignant tumors or other serious wasting diseases, which are prone to co-infection and bleeding; 8. Patients who have poor compliance, or fail to receive treatment as required; 9. For some reason, it is impossible to judge the curative effect or incomplete data affects the curative effect and judgement; 10. As a result of drug abuse or drug treatment, caused by insomnia patients; 11. Sleep disorders caused by long-term excessive drinking of alcohol, coffee, strong tea, etc., and adverse life factors; 12. A pregnant, menstruating, or lactating woman.

Design outcomes

Primary

MeasureTime frame
SAS;Stomach motion speed;Gastric secrete element;1HNMR;PSQI;Intestinal flora;Routine urine;Electrocardiogram;SDS;

Countries

China

Contacts

Public ContactJundong Jiao
24204264@qq.com13843169674

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026